Last update 01 Nov 2024

PYG x PPP1R15A

Basic Info

Related Targets
PYGPPP1R15A

Related

1
Drugs associated with PYG x PPP1R15A
GL-GP inhibitors(Boehringer Ingelheim)
Target
PPP1R15A x PYG
Mechanism
PPP1R15A inhibitors [+1]
Active Org.-
Originator Org.
Boehringer Ingelheim Pharma GmbH & Co., KG
Active Indication-
Inactive Indication
Diabetes Mellitus, Type 2
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with PYG x PPP1R15A
Login to view more data
100 Translational Medicine associated with PYG x PPP1R15A
Login to view more data
0 Patents (Medical) associated with PYG x PPP1R15A
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free